isomethyleugenol has been researched along with Idiopathic Pulmonary Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Miao, C; Xiong, Y; Zhang, G | 1 |
| Coward, WR; Feghali-Bostwick, CA; Jenkins, G; Pang, L; Watts, K | 1 |
1 review(s) available for isomethyleugenol and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
MicroRNAs in idiopathic pulmonary fibrosis, new research progress and their pathophysiological implication.
Topics: Biomarkers; DNA Methylation; Humans; Idiopathic Pulmonary Fibrosis; Methylation; MicroRNAs | 2018 |
1 other study(ies) available for isomethyleugenol and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.
Topics: Acetylation; Cell Line; Chemokine CXCL10; Chromobox Protein Homolog 5; Chromosomal Proteins, Non-Histone; Cytokines; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Idiopathic Pulmonary Fibrosis; Methylation; Promoter Regions, Genetic; Protein Binding; Repressor Proteins; RNA, Messenger; Transcription Factors | 2010 |